Jeannie Zhang

Title: Jeannie Zhang: Innovator in Pharmaceutical Synthesis

Introduction

Jeannie Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical synthesis, holding 2 patents that focus on innovative methods for synthesizing key intermediates used in important medications.

Latest Patents

One of his latest patents is a method for synthesizing a key intermediate of apixaban. This invention involves reacting a compound with 5-chloro-valeryl chloride in the presence of an inorganic base within an inert solvent. The resulting compound is produced under mild reaction conditions, making the process simple, cost-effective, and environmentally friendly, thus suitable for industrial production. Another notable patent is for synthesizing the rivaroxaban intermediate, specifically 4-(4-[(5S)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-YL]phenyl)morpholin-3-one. This method also emphasizes mild reaction conditions, convenient operations, and low production costs, reinforcing its environmental benefits and industrial applicability.

Career Highlights

Jeannie Zhang has worked with several reputable companies, including Shanghai Syncores Technologies Inc. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills in pharmaceutical research and development.

Collaborations

Throughout his career, Jeannie has collaborated with notable colleagues such as Luning Huang and Boyu Wang. These partnerships have contributed to his innovative work in the pharmaceutical industry.

Conclusion

Jeannie Zhang is a distinguished inventor whose work in synthesizing pharmaceutical intermediates has made a significant impact on the industry. His innovative methods not only enhance production efficiency but also prioritize environmental sustainability.